Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.
@article{Das2009Interleukin23SB, title={Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.}, author={Rupali Das and X. Chen and R. Komorowski and M. Hessner and W. Drobyski}, journal={Blood}, year={2009}, volume={113 10}, pages={ 2352-62 } }
Damage to the gastrointestinal tract during graft-versus-host disease (GVHD) from the conditioning regimen in conjunction with alloreactive donor T cells plays a pivotal role in the pathogenesis of this disease. In this study, we have identified secretion of interleukin-23 (IL-23) by donor antigen-presenting cells (APCs) as a critical event in the induction of GVHD of the colon linking conditioning regimen-induced mucosal injury and lipopolysaccharide (LPS) translocation to subsequent… CONTINUE READING
68 Citations
Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.
- Biology, Medicine
- Blood
- 2009
- 224
Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.
- Biology, Medicine
- Blood
- 2011
- 33
Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.
- Biology, Medicine
- Immunity
- 2012
- 395
Regulatory T cells and IL-17-producing cells in graft-versus-host disease.
- Biology, Medicine
- Immunotherapy
- 2011
- 34
A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease.
- Medicine
- Blood
- 2013
- 23
The IL-17 differentiation pathway and its role in transplant outcome.
- Medicine
- Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
- 2012
- 73
References
SHOWING 1-10 OF 54 REFERENCES
Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.
- Medicine
- The Journal of clinical investigation
- 1998
- 316
Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.
- Biology, Medicine
- Blood
- 2007
- 209
IL-12 is a central mediator of acute graft-versus-host disease in mice.
- Biology, Medicine
- Journal of immunology
- 1996
- 108
DIFFERENTIAL ACTIVITY OF IL-12 AND IL-23 IN MUCOSAL AND SYSTEMIC INNATE IMMUNE PATHOLOGY
- Medicine, Biology
- Immunity
- 2006
- 628
- PDF
Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis
- Biology, Medicine
- Immunity
- 2008
- 351
- PDF
IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract.
- Biology, Medicine
- Blood
- 2007
- 142
- PDF
Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease
- Biology, Medicine
- The Journal of experimental medicine
- 1992
- 380
- PDF
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
- Medicine
- The Journal of clinical investigation
- 2001
- 264
- PDF